Skip to main content
Top
Published in: Journal of Translational Medicine 1/2013

Open Access 01-12-2013 | Research

A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells

Authors: Daya Luo, James M Wilson, Nikki Harvel, Jimei Liu, Lirong Pei, Shuang Huang, LesleyAnn Hawthorn, Huidong Shi

Published in: Journal of Translational Medicine | Issue 1/2013

Login to get access

Abstract

In this study we performed a systematic evaluation of functional miRNA-mRNA interactions associated with the invasiveness of breast cancer cells using a combination of integrated miRNA and mRNA expression profiling, bioinformatics prediction, and functional assays. Analysis of the miRNA expression identified 11 miRNAs that were differentially expressed, including 7 down-regulated (miR-200c, miR-205, miR-203, miR-141, miR-34a, miR-183, and miR-375) and 4 up-regulated miRNAs (miR-146a, miR-138, miR-125b1 and miR-100), in invasive cell lines when compared to normal and less invasive cell lines. Transfection of miR-200c, miR-205, and miR-375 mimics into MDA-MB-231 cells led to the inhibition of in vitro cell migration and invasion. The integrated analysis of miRNA and mRNA expression identified 35 known and novel target genes of miR-200c, miR-205, and mir-375, including CFL2, LAMC1, TIMP2, ZEB1, CDH11, PRKCA, PTPRJ, PTPRM, LDHB, and SEC23A. Surprisingly, the majority of these genes (27 genes) were target genes of miR-200c, suggesting that miR-200c plays a pivotal role in regulating the invasiveness of breast cancer cells. We characterized one of the target genes of miR-200c, CFL2, and demonstrated that CFL2 is overexpressed in aggressive breast cancer cell lines and can be significantly down-regulated by exogenous miR-200c. Tissue microarray analysis further revealed that CFL2 expression in primary breast cancer tissue correlated with tumor grade. The results obtained from this study may improve our understanding of the role of these candidate miRNAs and their target genes in relation to breast cancer invasiveness and ultimately lead to the identification of novel biomarkers associated with prognosis.
Appendix
Available only for authorised users
Literature
3.
go back to reference Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65: 7065-7070. 10.1158/0008-5472.CAN-05-1783.CrossRefPubMed Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65: 7065-7070. 10.1158/0008-5472.CAN-05-1783.CrossRefPubMed
4.
go back to reference Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007, 131: 1109-1123. 10.1016/j.cell.2007.10.054.CrossRefPubMed Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007, 131: 1109-1123. 10.1016/j.cell.2007.10.054.CrossRefPubMed
5.
go back to reference Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009, 137: 1032-1046. 10.1016/j.cell.2009.03.047.PubMedCentralCrossRefPubMed Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009, 137: 1032-1046. 10.1016/j.cell.2009.03.047.PubMedCentralCrossRefPubMed
6.
go back to reference Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007, 449: 682-688. 10.1038/nature06174.CrossRefPubMed Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007, 449: 682-688. 10.1038/nature06174.CrossRefPubMed
7.
go back to reference Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA: Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010, 28: 341-347. 10.1038/nbt.1618.PubMedCentralCrossRefPubMed Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA: Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010, 28: 341-347. 10.1038/nbt.1618.PubMedCentralCrossRefPubMed
8.
go back to reference Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009, 137: 1005-1017. 10.1016/j.cell.2009.04.021.PubMedCentralCrossRefPubMed Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009, 137: 1005-1017. 10.1016/j.cell.2009.04.021.PubMedCentralCrossRefPubMed
9.
go back to reference Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006, 12: 895-904. 10.1038/nm1469.CrossRefPubMed Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006, 12: 895-904. 10.1038/nm1469.CrossRefPubMed
10.
11.
go back to reference Sreekumar R, Sayan BS, Mirnezami AH, Sayan AE: MicroRNA control of invasion and metastasis pathways. Frontiers Genet. 2011, 2: 58-CrossRef Sreekumar R, Sayan BS, Mirnezami AH, Sayan AE: MicroRNA control of invasion and metastasis pathways. Frontiers Genet. 2011, 2: 58-CrossRef
12.
13.
go back to reference Su S, Li Y, Luo Y, Sheng Y, Su Y, Padia RN, Pan ZK, Dong Z, Huang S: Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration. Oncogene. 2009, 28: 3047-3057. 10.1038/onc.2009.163.PubMedCentralCrossRefPubMed Su S, Li Y, Luo Y, Sheng Y, Su Y, Padia RN, Pan ZK, Dong Z, Huang S: Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration. Oncogene. 2009, 28: 3047-3057. 10.1038/onc.2009.163.PubMedCentralCrossRefPubMed
14.
go back to reference McCarty KS, Miller LS, Cox EB, Konrath J, McCarty KS: Estrogen receptor analyses, Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985, 109: 716-721.PubMed McCarty KS, Miller LS, Cox EB, Konrath J, McCarty KS: Estrogen receptor analyses, Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985, 109: 716-721.PubMed
15.
go back to reference Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008, 10: 593-601. 10.1038/ncb1722.CrossRefPubMed Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008, 10: 593-601. 10.1038/ncb1722.CrossRefPubMed
16.
go back to reference Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X: miR-375 Is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion via Targeting Transcription Factor SP1. Am J Pathol. 2011, 179: 2580-2588. 10.1016/j.ajpath.2011.07.037.PubMedCentralCrossRefPubMed Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X: miR-375 Is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion via Targeting Transcription Factor SP1. Am J Pathol. 2011, 179: 2580-2588. 10.1016/j.ajpath.2011.07.037.PubMedCentralCrossRefPubMed
17.
go back to reference Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006, 10: 515-527. 10.1016/j.ccr.2006.10.008.PubMedCentralCrossRefPubMed Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006, 10: 515-527. 10.1016/j.ccr.2006.10.008.PubMedCentralCrossRefPubMed
18.
go back to reference Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR: Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009, 69: 1279-1283. 10.1158/0008-5472.CAN-08-3559.PubMedCentralCrossRefPubMed Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR: Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009, 69: 1279-1283. 10.1158/0008-5472.CAN-08-3559.PubMedCentralCrossRefPubMed
19.
go back to reference Enerly E, Steinfeld I, Kleivi K, Leivonen S-K, Aure MR, Russnes HG, Ronneberg JA, Johnsen H, Navon R, Rodland E: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS One. 2011, 6: e16915-10.1371/journal.pone.0016915.PubMedCentralCrossRefPubMed Enerly E, Steinfeld I, Kleivi K, Leivonen S-K, Aure MR, Russnes HG, Ronneberg JA, Johnsen H, Navon R, Rodland E: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS One. 2011, 6: e16915-10.1371/journal.pone.0016915.PubMedCentralCrossRefPubMed
20.
go back to reference Genovesi LA, Carter KW, Gottardo NG, Giles KM, Dallas PB: Integrated Analysis of miRNA and mRNA Expression in Childhood Medulloblastoma Compared with Neural Stem Cells. PLoS One. 2011, 6: e23935-10.1371/journal.pone.0023935.PubMedCentralCrossRefPubMed Genovesi LA, Carter KW, Gottardo NG, Giles KM, Dallas PB: Integrated Analysis of miRNA and mRNA Expression in Childhood Medulloblastoma Compared with Neural Stem Cells. PLoS One. 2011, 6: e23935-10.1371/journal.pone.0023935.PubMedCentralCrossRefPubMed
21.
go back to reference Havelange V, Stauffer N, Heaphy CCE, Volinia S, Andreeff M, Marcucci G, Croce CM, Garzon R: Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling. Cancer. 2011, 117: 4696-4706. 10.1002/cncr.26096.PubMedCentralCrossRefPubMed Havelange V, Stauffer N, Heaphy CCE, Volinia S, Andreeff M, Marcucci G, Croce CM, Garzon R: Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling. Cancer. 2011, 117: 4696-4706. 10.1002/cncr.26096.PubMedCentralCrossRefPubMed
22.
go back to reference Ma L, Huang Y, Zhu W, Zhou S, Zhou J, Zeng F, Liu X, Zhang Y, Yu J: An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers. PLoS One. 2011, 6: e26502-10.1371/journal.pone.0026502.PubMedCentralCrossRefPubMed Ma L, Huang Y, Zhu W, Zhou S, Zhou J, Zeng F, Liu X, Zhang Y, Yu J: An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers. PLoS One. 2011, 6: e26502-10.1371/journal.pone.0026502.PubMedCentralCrossRefPubMed
23.
go back to reference Qin L-X: An Integrative Analysis of microRNA and mRNA Expression - A Case Study. Cancer Informatics. 2008, 6: 0- Qin L-X: An Integrative Analysis of microRNA and mRNA Expression - A Case Study. Cancer Informatics. 2008, 6: 0-
24.
go back to reference Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ: Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer. 2010, 103: 532-541. 10.1038/sj.bjc.6605787.PubMedCentralCrossRefPubMed Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ: Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer. 2010, 103: 532-541. 10.1038/sj.bjc.6605787.PubMedCentralCrossRefPubMed
25.
go back to reference Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ: Lysyl oxidase is essential for hypoxia-induced metastasis. Nature. 2006, 440: 1222-1226. 10.1038/nature04695.CrossRefPubMed Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ: Lysyl oxidase is essential for hypoxia-induced metastasis. Nature. 2006, 440: 1222-1226. 10.1038/nature04695.CrossRefPubMed
26.
go back to reference Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH: Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Breast Cancer Res Treat. 2012, 134: 989-1004. 10.1007/s10549-012-1986-8.CrossRefPubMed Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH: Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Breast Cancer Res Treat. 2012, 134: 989-1004. 10.1007/s10549-012-1986-8.CrossRefPubMed
27.
go back to reference Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 2007, 7: 55-10.1186/1471-2407-7-55.PubMedCentralCrossRefPubMed Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 2007, 7: 55-10.1186/1471-2407-7-55.PubMedCentralCrossRefPubMed
28.
go back to reference Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, Al-Tweigeri T, Ajarim D, Adra C: Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules. PLoS One. 2011, 6: e27339-10.1371/journal.pone.0027339.PubMedCentralCrossRefPubMed Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, Al-Tweigeri T, Ajarim D, Adra C: Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules. PLoS One. 2011, 6: e27339-10.1371/journal.pone.0027339.PubMedCentralCrossRefPubMed
29.
go back to reference Li Y, Guo Z, Chen H, Dong Z, Pan ZK, Ding H, Su SB, Huang S: HOXC8-Dependent Cadherin 11 Expression Facilitates Breast Cancer Cell Migration through Trio and Rac. Genes Cancer. 2011, 2: 880-888. 10.1177/1947601911433129.PubMedCentralCrossRefPubMed Li Y, Guo Z, Chen H, Dong Z, Pan ZK, Ding H, Su SB, Huang S: HOXC8-Dependent Cadherin 11 Expression Facilitates Breast Cancer Cell Migration through Trio and Rac. Genes Cancer. 2011, 2: 880-888. 10.1177/1947601911433129.PubMedCentralCrossRefPubMed
30.
go back to reference Hurteau GJ, Spivack SD, Brock GJ: Potential mRNA Degradation Targets of hsa-miR-200c. Cell Cycle. 2006, 5: 1951-1956. 10.4161/cc.5.17.3133.CrossRefPubMed Hurteau GJ, Spivack SD, Brock GJ: Potential mRNA Degradation Targets of hsa-miR-200c. Cell Cycle. 2006, 5: 1951-1956. 10.4161/cc.5.17.3133.CrossRefPubMed
31.
go back to reference Lonne G, Cornmark L, Zahirovic I, Landberg G, Jirstrom K, Larsson C: PKCalpha expression is a marker for breast cancer aggressiveness. Mol Cancer. 2010, 9: 76-10.1186/1476-4598-9-76.PubMedCentralCrossRefPubMed Lonne G, Cornmark L, Zahirovic I, Landberg G, Jirstrom K, Larsson C: PKCalpha expression is a marker for breast cancer aggressiveness. Mol Cancer. 2010, 9: 76-10.1186/1476-4598-9-76.PubMedCentralCrossRefPubMed
32.
go back to reference Yue CH, Chiu YW, Tung JN, Tzang BS, Shiu JJ, Huang WH, Liu JY, Hwang JM: Expression of protein kinase C alpha and the MZF-1 and Elk-1 transcription factors in human breast cancer cells. Chin J Physiol. 2012, 55: 31-36.CrossRefPubMed Yue CH, Chiu YW, Tung JN, Tzang BS, Shiu JJ, Huang WH, Liu JY, Hwang JM: Expression of protein kinase C alpha and the MZF-1 and Elk-1 transcription factors in human breast cancer cells. Chin J Physiol. 2012, 55: 31-36.CrossRefPubMed
33.
go back to reference Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, Guo XL, Dong LJ, He X, Qiao HX: Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/[beta]-catenin pathway. Oncogene. 2008, 28: 599-609.CrossRefPubMed Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, Guo XL, Dong LJ, He X, Qiao HX: Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/[beta]-catenin pathway. Oncogene. 2008, 28: 599-609.CrossRefPubMed
34.
go back to reference Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim Y-Y: An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell. 2011, 22: 1686-1698. 10.1091/mbc.E11-02-0103.PubMedCentralCrossRefPubMed Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim Y-Y: An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell. 2011, 22: 1686-1698. 10.1091/mbc.E11-02-0103.PubMedCentralCrossRefPubMed
35.
go back to reference Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nature medicine. 2011, 17: 1101-1108. 10.1038/nm.2401.PubMedCentralCrossRefPubMed Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nature medicine. 2011, 17: 1101-1108. 10.1038/nm.2401.PubMedCentralCrossRefPubMed
Metadata
Title
A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells
Authors
Daya Luo
James M Wilson
Nikki Harvel
Jimei Liu
Lirong Pei
Shuang Huang
LesleyAnn Hawthorn
Huidong Shi
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-57

Other articles of this Issue 1/2013

Journal of Translational Medicine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.